8 results
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
Guillain-Barre Syndrome ... meningococcal, H1N1) Clinical ... Clinical Features ... #management #treatment ... #neurology
Peri-operative Hyperthermia - Guidelines for Crises in Anaesthesia
If prolonged or ≥ 39 C this is a
39 C this is a clinical ... Treatment depends ... Anesthesiology #Anesthesia ... #Checklist #Diagnosis ... #Management #Workup
Cauda Equina Syndrome Overview

Cauda Equina Syndrome:
 • Prevalence: 1:33,000-100,000 ppl/yr
 • Incidence: 1.5-3.4 million ppl/yr
 •
• S - Saddle anesthesia ... cord • Guillain-Barre ... bladder for urinary retention ... axial T1 and T2 Treatment ... diagnosis #causes #neurology
CNS Manifestations of Systemic Lupus Erythematosus (SLE)

Clinical Manifestations: Demyelinating Syndrome, Headache, Movement disorders, Seizure disorders, Aseptic
Erythematosus (SLE) Clinical ... Demyelinating Syndrome ... APS), Secondary prevention ... Erythematosus #SLE #CNS #neurology ... cerebritis #diagnosis #management
Guillain-Barré Syndrome (GBS)
Acute autoimmune demyelinating polyradiculoneuropathy that presents with rapidly progressive flaccid weakness
Epidemiology:
 • Incidence: 1
Guillain-Barré Syndrome ... transplantation CLINICAL ... and cauda equina TREATMENT ... #Syndrome #diagnosis ... #management #neurology
10 Steps to Managing Guillain-Barre Syndrome:
1️⃣ When to suspect
2️⃣ How to Diagnose
3️⃣ When to admit to
Managing Guillain-Barre ... Syndrome: 1️⃣ ... 5️⃣ Treatment ... complications 8️⃣ Clinical ... #Management #Neurology
Clarkson’s Disease - Capillary leak syndrome
Epidemiology: Roughly 150 published cases, Median age 50 years, No sex
Capillary leak syndrome ... Relapsing-remitting course +++ Clinical ... tissues: Myalgia, paresthesia ... disease flares: • Prevention ... #diagnosis #management
IDSA Recommendations for Treating Coccidiodomycosis in HIV-AIDS
Treating Mild Infections (Such As Focal Pneumonia or asymptomatic patients
IDSA Recommendations ... with positive serology ... • Use until clinical ... #Prevention #Treatment ... #management #opportunistic